Shareholder Update: Expanding Global Reach with Upstream Dual Listing

Expanding Global Reach with Upstream Dual Listing

Shareholder Update:

Dear Valued Investor,

I am pleased to share an exciting update as we continue to execute our growth strategy. Following the successful launch of Citizen Green TV (CGTV) and our partnership with Grunt Style Foundation, GCAC has been approved for a dual listing on Upstream, a blockchain-powered securities exchange. Trading will begin on October 7, 2024, under the ticker symbol 'GCAC.'

Why This Matters

Upstream is the world's only regulated securities exchange using blockchain for efficient and transparent transactions. While U.S. and Canadian investors cannot trade on Upstream, this listing allows us to engage European and Rest of World (ROW) investors, particularly those who value blockchain's real-world applications.

For existing shareholders, this dual listing enhances GCAC's position by showcasing Efixii's blockchain technology to markets where blockchain is well integrated, especially in sectors like supply chain management, data transparency, and medical efficacy. Investors in Europe and Asia, who emphasize long-term utility and regulatory compliance, are a key focus for us.

We believe Upstream's investor base is aligned with long-term blockchain projects, particularly those offering tangible benefits in sectors like healthcare, supply chain, and legal compliance-making Efixii a natural fit.GCAC CEO, Brad Moore.

Engaging a Broader Audience

This dual listing reflects our commitment to introducing Efixii Uplift to investors who appreciate the importance of supply chain integrity and data transparency. In Europe, venture capitalists and institutional investors are typically risk-averse and tend to support companies offering practical blockchain solutions in regulated industries. Showing how it can work in industries such as cannabis and CBD is perfect example.

We believe Upstream's investor base is aligned with long-term blockchain projects, particularly those offering tangible benefits in sectors like healthcare, supply chain, and legal compliance-making Efixii a natural fit.

Efixii's Global Value Proposition

Efixii addresses the growing global demand for medical efficacy verification, product traceability, and consumer transparency. Its ability to provide NFT-based coupons, verified through blockchain, positions it to disrupt traditional supply chains in regions prioritizing compliance and transparency.

By presenting Efixii's solutions to international investors, especially those on Upstream, we align GCAC with industries focused on transparency and regulation, such as cannabis and healthcare. Additionally this awareness creates revenue possibilities in markets outside of North American for GCAC.

Looking Ahead

As we expand our global footprint through this dual listing, we remain committed to using Efixii's patented technology to deliver real-world solutions that drive growth. Today, this includes supporting veterans by offering safer alternatives to opioids, a very noble and worthwhile cause.

Thank you for your continued trust and support. We look forward to further updates as we strengthen our presence in global markets.

Sincerely,

Brad Moore

CEO, GCAC